The European TREatment of ATopic eczema (TREAT) Registry Taskforce survey: prescribing practices in Europe for phototherapy and systemic therapy in adult patients with moderate‐to‐severe atopic eczema*
F.M. Vermeulen(Amsterdam University Medical Centers), Carsten Flohr(King's College London), Wouter Ouwerkerk(University of Amsterdam), Louise A. A. Gerbens(Amsterdam UMC Location University of Amsterdam), Christian Vestergaard(Aarhus University), Kirsty Logan(King's College London), Jochen Schmitt(University Hospital Carl Gustav Carus), Phyllis I. Spuls, Mette Deleuran(Aarhus University Hospital), Alan D. Irvine(Trinity College Dublin)
Cited by 44
Related Papers
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2.1k
Atopic dermatitis
|Nature Reviews Disease Primers|2018|1.5k
The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
|Allergy|2018|1.5k
Definition of treatment goals for moderate to severe psoriasis: a European consensus
|Archives of Dermatological Research|2010|892